Cannara Biotech Inc.
LOVFF
$0.9125
$0.00610.67%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -60.11% | 183.00% | 157.88% | -266.22% | -55.59% |
| Total Depreciation and Amortization | -12.59% | 16.36% | 2.57% | -8.55% | 19.73% |
| Total Amortization of Deferred Charges | 62.42% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 135.97% | -190.77% | -129.87% | 349.08% | 162.88% |
| Change in Net Operating Assets | 242.07% | -95.84% | 358.39% | 78.01% | -156.57% |
| Cash from Operations | 82.27% | -26.69% | 82.63% | 203.10% | -73.54% |
| Capital Expenditure | -145.74% | 84.08% | -171.52% | 58.99% | -52.07% |
| Sale of Property, Plant, and Equipment | -73.81% | -99.45% | -- | -- | -95.85% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.48% | 16.55% | -13.68% | 25.10% | -24.64% |
| Cash from Investing | -167.83% | 54.02% | 13.42% | 60.01% | -64.83% |
| Total Debt Issued | -- | -100.00% | 120.00% | -60.00% | 66.67% |
| Total Debt Repaid | -4.75% | 81.00% | -437.69% | -7.40% | -0.08% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 98.42% | -34.12% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 9.95% | -333.50% | 80.42% | 13.19% | 23.05% |
| Cash from Financing | 36.33% | -51.47% | -34.37% | -345.07% | 130.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 213.54% | -50.71% | 368.44% | 130.60% | -756.43% |